The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Pre-Transplant Factors Influencing Rates of Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients
Gastroenterology Res. 2021 Jun;14(3):190-193. doi: 10.14740/gr1402. Epub 2021 Jun 19.
Kelly M Zucker1, Paul A Gomez2, Olivia Kezirian3, Shivang Mehta4
Author information
1Department of Gastroenterology, University of Arizona College of Medicine Phoenix, Banner University Medical Center-Phoenix, Phoenix, AZ, USA.
2Department of Internal Medicine, University of Arizona College of Medicine Phoenix, Banner University Medical Center-Phoenix, Phoenix, AZ, USA.
3Department of Data Management, University of Arizona College of Medicine Phoenix, Banner University Medical Center-Phoenix, Phoenix, AZ, USA.
4Transplant and Advanced Liver Disease Center, University of Arizona College of Medicine Phoenix, Banner University Medical Center-Phoenix, Phoenix, AZ, USA.
Abstract
Background: The aim of the study was to determine factors influencing hepatocellular carcinoma (HCC) recurrence in a cohort of patients who underwent liver transplantation (LT) at a large, tertiary-care medical center.
Methods: A total of 132 patients with the diagnosis of HCC at time of transplant were evaluated for HCC recurrence over a 7-year period. Nine patients were found to have HCC recur post-LT.
Results: No significant demographic values were found to indicate recurrence. Pre-LT factors potentially influencing HCC recurrence rates included number of days between HCC diagnosis and date of LT (P = 0.015), caudate lobe involvement (P = 0.019), increased use of radiation therapies pre-LT (P = 0.011), and total number of locoregional therapies (LRT) pre-LT (P < 0.001). Post-transplant outcomes demonstrated a significant difference in deep venous thrombosis (DVT) in the recurrent vs. non-recurrent groups (P = 0.035).
Conclusions: The prevalence of HCC recurrence in this study was lower than the national average, yet difficulty still exists in predicting pre-LT factors which may influence HCC recurrence rates.